
There is a global and continuing increase in the population of elderly zzso This is particularly true among patients with cancer including those receiving zzso There are no guidelines that in particular address prophylaxis of zzso zzso and vomiting zzso in the zzso zzso have a potential decreased risk of zzso due to the fact that they are often treated with less zzso chemotherapy and due to the fact that high age is zzso On the other hand, elderly have an increased risk of toxicity from zzso due to age-related decrease in organ function, use of zzso with increased risk of zzso interactions and due to zzso Compliance needs to be carefully zzso particularly in patients with high risk of zzso such as elderly with zzso and impaired zzso 

